{'fraction_non_alphanumeric': 0.015086206896551725, 'fraction_numerical': 0.004310344827586207, 'mean_word_length': 5.038961038961039, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
New findings bring hope to Vancouver AIDS conference.


 Significant progress in clinical and basic research was reported at the International Conference on AIDS. Dramatic reductions in HIV viral load were attributed to protease inhibitor therapy, although issues remain about long-term side effects and resistance to the drugs. Researchers continue to work on developing a safe and effective vaccine for HIV, with 16 experimental vaccines now in clinical trials.
